AustralieFrV1, PascalFrancis, Curation, bibRecord, 001501

Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?

Identifieur interne : 001501 ( PascalFrancis/Curation ); précédent : 001500; suivant : 001502

Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?

Auteurs : Pierre Amarenco [France] ; Geoffrey A. Donnan [Australie]

Source :

Stroke : (1970) [ 0039-2499 ] ; 2004.

RBID : Pascal:04-0604468

Descripteurs français

Pascal (Inist)
- Système nerveux pathologie, Homme, Clopidogrel, Cérébrovasculaire pathologie, Acétylsalicylique acide, Accident cérébrovasculaire, Inhibiteur thromboagrégation, Antipyrétique, Analgésique, Antiinflammatoire non stéroïde.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Acetylsalicylic acid, Analgesic, Antiplatelet agent, Antipyretic, Cerebrovascular disease, Clopidogrel, Human, Nervous system diseases, Non steroidal antiinflammatory agent, Stroke.

A01	`01`	`1`		`@0 0039-2499`
A02	`01`			`@0 SJCCA7`
A03		`1`		`@0 Stroke : (1970)`
A05				`@2 35`
A06				`@2 11`
A08	`01`	`1`	`ENG`	`@1 Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?`
A11	`01`	`1`		`@1 AMARENCO (Pierre)`
A11	`02`	`1`		`@1 DONNAN (Geoffrey A.)`
A14	`01`			`@1 Bichat Hospital and Medical School @2 Paris @3 FRA @Z 1 aut.`
A14	`02`			`@1 University of Melbourne @3 AUS @Z 2 aut.`
A20				`@1 2606-2608`
A21				`@1 2004`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 4004 @5 354000120554310400`
A44				`@0 0000 @1 © 2004 INIST-CNRS. All rights reserved.`
A45				`@0 10 ref.`
A47	`01`	`1`		`@0 04-0604468`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Stroke : (1970)`
A66	`01`			`@0 USA`
C02	`01`	`X`		`@0 002B17C`
C02	`02`	`X`		`@0 002B17A03`
C02	`03`	`X`		`@0 002B02G`
C03	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 01`
C03	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 01`
C03	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 01`
C03	`02`	`X`	`FRE`	`@0 Homme @5 02`
C03	`02`	`X`	`ENG`	`@0 Human @5 02`
C03	`02`	`X`	`SPA`	`@0 Hombre @5 02`
C03	`03`	`X`	`FRE`	`@0 Clopidogrel @2 NK @2 FR @5 03`
C03	`03`	`X`	`ENG`	`@0 Clopidogrel @2 NK @2 FR @5 03`
C03	`03`	`X`	`SPA`	`@0 Clopidogrel @2 NK @2 FR @5 03`
C03	`04`	`X`	`FRE`	`@0 Cérébrovasculaire pathologie @5 04`
C03	`04`	`X`	`ENG`	`@0 Cerebrovascular disease @5 04`
C03	`04`	`X`	`SPA`	`@0 Vaso sanguíneo encéfalo patología @5 04`
C03	`05`	`X`	`FRE`	`@0 Acétylsalicylique acide @2 NK @2 FR @5 05`
C03	`05`	`X`	`ENG`	`@0 Acetylsalicylic acid @2 NK @2 FR @5 05`
C03	`05`	`X`	`SPA`	`@0 Acetilsalicilico ácido @2 NK @2 FR @5 05`
C03	`06`	`X`	`FRE`	`@0 Accident cérébrovasculaire @5 07`
C03	`06`	`X`	`ENG`	`@0 Stroke @5 07`
C03	`06`	`X`	`SPA`	`@0 Accidente cerebrovascular @5 07`
C03	`07`	`X`	`FRE`	`@0 Inhibiteur thromboagrégation @5 25`
C03	`07`	`X`	`ENG`	`@0 Antiplatelet agent @5 25`
C03	`07`	`X`	`SPA`	`@0 Inhibidor tromboagregación @5 25`
C03	`08`	`X`	`FRE`	`@0 Antipyrétique @5 26`
C03	`08`	`X`	`ENG`	`@0 Antipyretic @5 26`
C03	`08`	`X`	`SPA`	`@0 Antipirético @5 26`
C03	`09`	`X`	`FRE`	`@0 Analgésique @5 27`
C03	`09`	`X`	`ENG`	`@0 Analgesic @5 27`
C03	`09`	`X`	`SPA`	`@0 Analgésico @5 27`
C03	`10`	`X`	`FRE`	`@0 Antiinflammatoire non stéroïde @5 28`
C03	`10`	`X`	`ENG`	`@0 Non steroidal antiinflammatory agent @5 28`
C03	`10`	`X`	`SPA`	`@0 Antiinflamatorio no esteroide @5 28`
C07	`01`	`X`	`FRE`	`@0 Encéphale pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Appareil circulatoire pathologie @5 39`
C07	`03`	`X`	`ENG`	`@0 Cardiovascular disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Vaisseau sanguin pathologie @5 40`
C07	`04`	`X`	`ENG`	`@0 Vascular disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Vaso sanguíneo patología @5 40`
C07	`05`	`X`	`FRE`	`@0 Inhibiteur enzyme @5 41`
C07	`05`	`X`	`ENG`	`@0 Enzyme inhibitor @5 41`
C07	`05`	`X`	`SPA`	`@0 Inhibidor enzima @5 41`
C07	`06`	`X`	`FRE`	`@0 Prostaglandin-endoperoxide synthase @2 FE @5 42`
C07	`06`	`X`	`ENG`	`@0 Prostaglandin-endoperoxide synthase @2 FE @5 42`
C07	`06`	`X`	`SPA`	`@0 Prostaglandin-endoperoxide synthase @2 FE @5 42`
C07	`07`	`X`	`FRE`	`@0 Oxidoreductases @2 FE`
C07	`07`	`X`	`ENG`	`@0 Oxidoreductases @2 FE`
C07	`07`	`X`	`SPA`	`@0 Oxidoreductases @2 FE`
C07	`08`	`X`	`FRE`	`@0 Enzyme @2 FE`
C07	`08`	`X`	`ENG`	`@0 Enzyme @2 FE`
C07	`08`	`X`	`SPA`	`@0 Enzima @2 FE`
C07	`09`	`X`	`FRE`	`@0 Salicylés @5 43`
C07	`09`	`X`	`ENG`	`@0 Salicylates @5 43`
C07	`09`	`X`	`SPA`	`@0 Salicilatos @5 43`
C07	`10`	`X`	`FRE`	`@0 Thiénopyridine dérivé @4 INC @5 86`
N21				`@1 348`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004C13

Links to Exploration step

Pascal:04-0604468

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?</title>
<author><name sortKey="Amarenco, Pierre" sort="Amarenco, Pierre" uniqKey="Amarenco P" first="Pierre" last="Amarenco">Pierre Amarenco</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Bichat Hospital and Medical School</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Donnan, Geoffrey A" sort="Donnan, Geoffrey A" uniqKey="Donnan G" first="Geoffrey A." last="Donnan">Geoffrey A. Donnan</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>University of Melbourne</s1>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0604468</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 04-0604468 INIST</idno>
<idno type="RBID">Pascal:04-0604468</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">004C13</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001501</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?</title>
<author><name sortKey="Amarenco, Pierre" sort="Amarenco, Pierre" uniqKey="Amarenco P" first="Pierre" last="Amarenco">Pierre Amarenco</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Bichat Hospital and Medical School</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Donnan, Geoffrey A" sort="Donnan, Geoffrey A" uniqKey="Donnan G" first="Geoffrey A." last="Donnan">Geoffrey A. Donnan</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>University of Melbourne</s1>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Stroke : (1970)</title>
<title level="j" type="abbreviated">Stroke : (1970)</title>
<idno type="ISSN">0039-2499</idno>
<imprint><date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Stroke : (1970)</title>
<title level="j" type="abbreviated">Stroke : (1970)</title>
<idno type="ISSN">0039-2499</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acetylsalicylic acid</term>
<term>Analgesic</term>
<term>Antiplatelet agent</term>
<term>Antipyretic</term>
<term>Cerebrovascular disease</term>
<term>Clopidogrel</term>
<term>Human</term>
<term>Nervous system diseases</term>
<term>Non steroidal antiinflammatory agent</term>
<term>Stroke</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Homme</term>
<term>Clopidogrel</term>
<term>Cérébrovasculaire pathologie</term>
<term>Acétylsalicylique acide</term>
<term>Accident cérébrovasculaire</term>
<term>Inhibiteur thromboagrégation</term>
<term>Antipyrétique</term>
<term>Analgésique</term>
<term>Antiinflammatoire non stéroïde</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0039-2499</s0>
</fA01>
<fA02 i1="01"><s0>SJCCA7</s0>
</fA02>
<fA03 i2="1"><s0>Stroke : (1970)</s0>
</fA03>
<fA05><s2>35</s2>
</fA05>
<fA06><s2>11</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>AMARENCO (Pierre)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>DONNAN (Geoffrey A.)</s1>
</fA11>
<fA14 i1="01"><s1>Bichat Hospital and Medical School</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>University of Melbourne</s1>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA20><s1>2606-2608</s1>
</fA20>
<fA21><s1>2004</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>4004</s2>
<s5>354000120554310400</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2004 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>10 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>04-0604468</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Stroke : (1970)</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B17C</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17A03</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B02G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Homme</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Human</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Hombre</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Clopidogrel</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Clopidogrel</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Clopidogrel</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Cérébrovasculaire pathologie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Cerebrovascular disease</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Vaso sanguíneo encéfalo patología</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Acétylsalicylique acide</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Acetylsalicylic acid</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Acetilsalicilico ácido</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Accident cérébrovasculaire</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Stroke</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Accidente cerebrovascular</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Inhibiteur thromboagrégation</s0>
<s5>25</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Antiplatelet agent</s0>
<s5>25</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Inhibidor tromboagregación</s0>
<s5>25</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Antipyrétique</s0>
<s5>26</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Antipyretic</s0>
<s5>26</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Antipirético</s0>
<s5>26</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Analgésique</s0>
<s5>27</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Analgesic</s0>
<s5>27</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Analgésico</s0>
<s5>27</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Antiinflammatoire non stéroïde</s0>
<s5>28</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Non steroidal antiinflammatory agent</s0>
<s5>28</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Antiinflamatorio no esteroide</s0>
<s5>28</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Vaisseau sanguin pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Vascular disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Vaso sanguíneo patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Inhibiteur enzyme</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Enzyme inhibitor</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Inhibidor enzima</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Prostaglandin-endoperoxide synthase</s0>
<s2>FE</s2>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Prostaglandin-endoperoxide synthase</s0>
<s2>FE</s2>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Prostaglandin-endoperoxide synthase</s0>
<s2>FE</s2>
<s5>42</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Oxidoreductases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Oxidoreductases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Oxidoreductases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Enzima</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Salicylés</s0>
<s5>43</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Salicylates</s0>
<s5>43</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Salicilatos</s0>
<s5>43</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE"><s0>Thiénopyridine dérivé</s0>
<s4>INC</s4>
<s5>86</s5>
</fC07>
<fN21><s1>348</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001501 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001501 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:04-0604468
   |texte=   Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?

Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri